Device is manufactured exclusively for brainlab ag to be used with the stereotactic and navigation instruments.Currently the data is quite poor and investigations are ongoing.Mfr pajunk gmbh medizintechnologie is in contact with the initally reporting hospital as well as with distributor/ customer brainlab in order to find out more details.Trend analysis as well as batch record do not indicate any adverse result nor abnormality.This is the first reported incident of this kind with the reported device malfunction.The device urgently needs to be analyzed.As soon as more information is available an updated report will be sent in to the food and drug administration.2019-12-17 we received the following: "our clinical specialist is in contact with mrs.(b)(6), the administrative nurse at (b)(6) and they informed us that the incident occurred with dr.(b)(6) and (b)(6).The biopsy needle was cleared by (b)(6) risk management to be sent off to the manufacturer, however, by the time they received approval the device went missing.(b)(6) is currently investigating the location of the device, and will inform us once located by email.Mrs.(b)(6) is also in contact with (b)(6) (who submitted the report to fda) from (b)(6) risk management and will email us with an update once available.We are waiting on feedback regarding more complete description of this incident from dr.(b)(6) and (b)(6)." 2020-02-07 upon request we did receive the following: "based on information provided by the hospital administrative nurse ms.(b)(6), the biopsy needle was cleared by (b)(6) risk management to be sent off to the manufacturer, however, by the time they received approval the device went missing.Brainlab followed up with ms.(b)(6) but did not get any further investigation result about the location of the biopsy needle.Based also on information provided ms.(b)(6), the incident occurred with dr.(b)(6) and (b)(6).Brainlab representative met with dr.(b)(6) and (b)(6) and they both do not recall the events that occurred in (b)(6) 2019.Dr.(b)(6) expressed that they have not had any issues using the biopsy needle since.".Based on risk assessment and clinical assessment file is considered as closed.
|